Product
Sodium Glucose Co-transporter 2 Inhibitor
Aliases
Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
2 clinical trials
2 indications
Indication
Coronary Artery DiseaseIndication
Atrial FibrillationClinical trial
The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrium Remodeling in Non-valvular Paroxysmal Atrial Fibrillation PatientsStatus: Not yet recruiting, Estimated PCD: 2024-08-01